{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:06:14Z","timestamp":1756191974896,"version":"3.34.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T00:00:00Z","timestamp":1209513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s12028-008-9096-5","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T19:54:44Z","timestamp":1209498884000},"page":"247-252","source":"Crossref","is-referenced-by-count":21,"title":["Lysergic Acid Amide-Induced Posterior Reversible Encephalopathy Syndrome with Status Epilepticus"],"prefix":"10.1007","volume":"9","author":[{"given":"Stephane","family":"Legriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Spreux-Varoquaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelie","family":"Birenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Laure","family":"Chadenat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Mignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Abbosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Henry-Lagarrigue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Revault D\u2019Allonnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Guezennec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Troche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Pierre","family":"Bedos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,30]]},"reference":[{"key":"9096_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et\u00a0al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494\u2013500.","journal-title":"N Engl J Med"},{"key":"9096_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00134-006-0459-0","volume":"33","author":"G Servillo","year":"2007","unstructured":"Servillo G, Bifulco F, De Robertis E, et\u00a0al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33:230\u20136.","journal-title":"Intensive Care Med"},{"key":"9096_CR3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665\u201375.","journal-title":"Lancet"},{"key":"9096_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(00)02539-3","volume":"356","author":"CJ Vaughan","year":"2000","unstructured":"Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411\u20137.","journal-title":"Lancet"},{"key":"9096_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2004.03.003","volume":"102","author":"JH Halpern","year":"2004","unstructured":"Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004;102:131\u20138.","journal-title":"Pharmacol Ther"},{"key":"9096_CR6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1212\/01.wnl.0000269780.45472.16","volume":"69","author":"OS Kozak","year":"2007","unstructured":"Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology. 2007;69:894\u20137.","journal-title":"Neurology"},{"key":"9096_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1552-6569.2004.tb00223.x","volume":"14","author":"C Lamy","year":"2004","unstructured":"Lamy C, Oppenheim C, Meder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004;14:89\u201396.","journal-title":"J Neuroimaging"},{"issue":"Suppl 4","key":"9096_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.0013-9580.2004.04014.x","volume":"45","author":"AJ Cole","year":"2004","unstructured":"Cole AJ. Status epilepticus and periictal imaging. Epilepsia. 2004;45(Suppl 4):72\u20137.","journal-title":"Epilepsia"},{"key":"9096_CR9","first-page":"205","volume":"65","author":"VH Lee","year":"2008","unstructured":"Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205\u201310.","journal-title":"Arch Neurol"},{"key":"9096_CR10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1440-1789.2007.00771.x","volume":"27","author":"R Okeda","year":"2007","unstructured":"Okeda R, Kawamoto T, Tanaka E, Shimizu H. An autopsy case of drug-induced diffuse cerebral axonopathic leukoencephalopathy: the pathogenesis in relation to reversible posterior leukoencephalopathy syndrome. Neuropathology. 2007;27:364\u201370.","journal-title":"Neuropathology"},{"key":"9096_CR11","doi-asserted-by":"crossref","unstructured":"Lai CC, Chen SJ, Lien SH, Lo CP, Cheng SN. Posterior reversible encephalopathy in a child with Langerhans cell histiocytosis following allogeneic PBSCT treatment with cyclosporine. Eur J Pediatr. 2007; doi: 10.1007\/s00431-007-0564-2 .","DOI":"10.1007\/s00431-007-0564-2"},{"key":"9096_CR12","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1200\/JCO.2007.10.9991","volume":"25","author":"W Irvin","year":"2007","unstructured":"Irvin W, MacDonald G, Smith JK, Kim WY. Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol. 2007;25:2484\u20136.","journal-title":"J Clin Oncol"},{"key":"9096_CR13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archneur.64.5.746","volume":"64","author":"S Nagel","year":"2007","unstructured":"Nagel S, Kohrmann M, Huttner HB, Storch-Hagenlocher B, Schwab S. Linezolid-induced posterior reversible leukoencephalopathy syndrome. Arch Neurol. 2007;64:746\u20138.","journal-title":"Arch Neurol"},{"key":"9096_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pbc.20731","volume":"48","author":"AY Minn","year":"2007","unstructured":"Minn AY, Fisher PG, Barnes PD, Dahl GV. A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. Pediatr Blood Cancer. 2007;48:213\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"9096_CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3816\/CCC.2007.n.009","volume":"6","author":"MR Skelton","year":"2007","unstructured":"Skelton MR, Goldberg RM, O\u2019Neil BH. A case of oxaliplatin-related posterior reversible encephalopathy syndrome. Clin Colorectal Cancer. 2007;6:386\u20138.","journal-title":"Clin Colorectal Cancer"},{"key":"9096_CR16","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1200\/JCO.2006.08.4608","volume":"24","author":"R Govindarajan","year":"2006","unstructured":"Govindarajan R, Adusumilli J, Baxter DL, El-Khoueiry A, Harik SI. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43\u20139006. J Clin Oncol. 2006;24:e48.","journal-title":"J Clin Oncol"},{"key":"9096_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.2006.06157.x","volume":"134","author":"P Greaves","year":"2006","unstructured":"Greaves P, Oakervee H, Kon SS, Jones R, Farah N. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia. Br J Haematol. 2006;134:251.","journal-title":"Br J Haematol"},{"key":"9096_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.smj.0000215739.90211.3b","volume":"99","author":"FJ Moawad","year":"2006","unstructured":"Moawad FJ, Hartzell JD, Biega TJ, Lettieri CJ. Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose. South Med J. 2006;99:511\u20134.","journal-title":"South Med J"},{"key":"9096_CR19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMc052954","volume":"354","author":"C Ozcan","year":"2006","unstructured":"Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006;354:980\u20132; discussion-2.","journal-title":"N Engl J Med"},{"key":"9096_CR20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.33588\/rn.4109.2005261","volume":"41","author":"LM Romano","year":"2005","unstructured":"Romano LM, de Robles P, Ioli P, Garcia-Saiz E. [Posterior reversible leukoencephalopathy syndrome caused by cisplatin: a case report.]. Rev Neurol. 2005;41:573\u20134.","journal-title":"Rev Neurol"},{"key":"9096_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.rhu.0000164825.63063.43","volume":"11","author":"KC Shin","year":"2005","unstructured":"Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YW. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol. 2005;11:164\u20136.","journal-title":"J Clin Rheumatol"},{"key":"9096_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000087720","volume":"54","author":"M Nakajima","year":"2005","unstructured":"Nakajima M. Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with miller-fisher syndrome. Eur Neurol. 2005;54:58\u201360.","journal-title":"Eur Neurol"},{"key":"9096_CR23","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/keh305","volume":"43","author":"CP Mavragani","year":"2004","unstructured":"Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Boletis I, Tzioufas AG, Voulgarelis M. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford). 2004;43:1450\u20131.","journal-title":"Rheumatology (Oxford)"},{"key":"9096_CR24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.33588\/rn.3906.2004075","volume":"39","author":"FA Martinez-Garcia","year":"2004","unstructured":"Martinez-Garcia FA, Jimenez-Gomez MR, Bixquert-Genoves D, Rodriguez-Hilario H, Meca-Lallana JE, Fernandez-Barreiro A. [Posterior reversible encephalopathy in a 12-year-old female with nephrotic syndrome and methylprednisolone therapy]. Rev Neurol. 2004;39:592\u20134.","journal-title":"Rev Neurol"},{"key":"9096_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.20147","volume":"77","author":"CS Tam","year":"2004","unstructured":"Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol. 2004;77:72\u20136.","journal-title":"Am J Hematol"},{"key":"9096_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2141.2003.04447.x","volume":"122","author":"R Wong","year":"2003","unstructured":"Wong R, Beguelin GZ, de Lima M, et\u00a0al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2003;122:128\u201334.","journal-title":"Br J Haematol"},{"key":"9096_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1468-1331.2003.00608_1.x","volume":"10","author":"M Cosottini","year":"2003","unstructured":"Cosottini M, Lazzarotti G, Ceravolo R, Michelassi MC, Canapicchi R, Murri L. Cyclosporine-related posterior reversible encephalopathy syndrome (PRES) in non-transplant patient: a case report and literature review. Eur J Neurol. 2003;10:461\u20132.","journal-title":"Eur J Neurol"},{"key":"9096_CR28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0750-7658(03)00097-2","volume":"22","author":"T Lepoivre","year":"2003","unstructured":"Lepoivre T, Treilhaud M, Auffray-Calvier E, Rigal JC, Blanloeil Y. [Posterior reversible encephalopathy syndrome: about 2 cases related to the cyclosporine]. Ann Fr Anesth Reanim. 2003;22:466\u20139.","journal-title":"Ann Fr Anesth Reanim"},{"key":"9096_CR29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0895-7061(02)02264-1","volume":"15","author":"V Giner","year":"2002","unstructured":"Giner V, Fernandez C, Esteban MJ, et\u00a0al. Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report. Am J Hypertens. 2002;15:465\u20137.","journal-title":"Am J Hypertens"},{"key":"9096_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0730-725X(01)00217-X","volume":"19","author":"MT Russell","year":"2001","unstructured":"Russell MT, Nassif AS, Cacayorin ED, Awwad E, Perman W, Dunphy F. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging. 2001;19:129\u201332.","journal-title":"Magn Reson Imaging"},{"key":"9096_CR31","first-page":"347","volume":"98","author":"I Mathy","year":"1998","unstructured":"Mathy I, Gille M, Van Raemdonck F, Delbecq J, Depre A. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg. 1998;98:347\u201351.","journal-title":"Acta Neurol Belg"},{"key":"9096_CR32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(08)60458-4","volume":"371","author":"RS Tattersall","year":"2008","unstructured":"Tattersall RS, Boulton JG, Amos RS. Stiff and partly blind\u2013after a first dose of steroid. Lancet. 2008;371:1044.","journal-title":"Lancet"},{"key":"9096_CR33","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/524740","volume":"46","author":"AL Ridolfo","year":"2008","unstructured":"Ridolfo AL, Resta F, Milazzo L, et\u00a0al. Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2008;46:e19\u201322.","journal-title":"Clin Infect Dis"},{"key":"9096_CR34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1634\/theoncologist.12-11-1332","volume":"12","author":"A Rajasekhar","year":"2007","unstructured":"Rajasekhar A, George TJ Jr. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist. 2007;12:1332\u20135.","journal-title":"Oncologist"},{"key":"9096_CR35","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1200\/JCO.2007.13.5954","volume":"25","author":"DM Pinedo","year":"2007","unstructured":"Pinedo DM, Shah-Khan F, Shah PC. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin. J Clin Oncol. 2007;25:5320\u20131.","journal-title":"J Clin Oncol"},{"key":"9096_CR36","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/JCO.2007.12.8710","volume":"25","author":"G Martin","year":"2007","unstructured":"Martin G, Bellido L, Cruz JJ. Reversible posterior leukoencephalopathy syndrome induced by sunitinib. J Clin Oncol. 2007;25:3559.","journal-title":"J Clin Oncol"},{"key":"9096_CR37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/annonc\/mdl436","volume":"18","author":"S Vieillot","year":"2007","unstructured":"Vieillot S, Pouessel D, de Champfleur NM, Becht C, Culine S. Reversible posterior leukoencephalopathy syndrome after carboplatin therapy. Ann Oncol. 2007;18:608\u20139.","journal-title":"Ann Oncol"},{"key":"9096_CR38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archneur.63.10.1475","volume":"63","author":"JA Allen","year":"2006","unstructured":"Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab\/FOLFIRI regimen for metastatic colon cancer. Arch Neurol. 2006;63:1475\u20138.","journal-title":"Arch Neurol"},{"key":"9096_CR39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ajh.20772","volume":"82","author":"B Saito","year":"2007","unstructured":"Saito B, Nakamaki T, Nakashima H, et\u00a0al. Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia. Am J Hematol. 2007;82:304\u20136.","journal-title":"Am J Hematol"},{"key":"9096_CR40","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMc052954","volume":"354","author":"P Glusker","year":"2006","unstructured":"Glusker P, Recht L, Lane B. Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab. N Engl J Med. 2006;354:980\u20131.","journal-title":"N Engl J Med"},{"key":"9096_CR41","first-page":"188","volume":"15","author":"CE Doss-Esper","year":"2005","unstructured":"Doss-Esper CE, Singhal AB, Smith MS, Henderson GV. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome. J Neuroimaging. 2005;15:188\u201392.","journal-title":"J Neuroimaging"},{"key":"9096_CR42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2169\/internalmedicine.42.624","volume":"42","author":"T Nakazato","year":"2003","unstructured":"Nakazato T, Nagasaki A, Nakamura K, et\u00a0al. Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy. Intern Med. 2003;42:624\u20135.","journal-title":"Intern Med"},{"key":"9096_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000065395","volume":"37","author":"B Rathi","year":"2002","unstructured":"Rathi B, Azad RK, Vasudha N, Hissaria P, Sawlani V, Gupta RK. l-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia. Pediatr Neurosurg. 2002;37:203\u20135.","journal-title":"Pediatr Neurosurg"},{"key":"9096_CR44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1023\/A:1012248800195","volume":"12","author":"MJ Edwards","year":"2001","unstructured":"Edwards MJ, Walker R, Vinnicombe S, Barlow C, MacCallum P, Foran JM. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol. 2001;12:1327\u20139.","journal-title":"Ann Oncol"},{"key":"9096_CR45","first-page":"305","volume":"21","author":"E Rodriguez Gomez","year":"2001","unstructured":"Rodriguez Gomez E, Rodriguez Gomez FJ, Merino MJ, et\u00a0al. [Reversible posterior leukoencephalopathy, severe hypertension, and cocaine abuse]. Nefrologia. 2001;21:305\u20138.","journal-title":"Nefrologia"},{"key":"9096_CR46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s002340000482","volume":"42","author":"J Honkaniemi","year":"2000","unstructured":"Honkaniemi J, Kahara V, Dastidar P, et\u00a0al. Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology. 2000;42:895\u20139.","journal-title":"Neuroradiology"},{"key":"9096_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bmj.319.7207.455a","volume":"319","author":"MB Lewis","year":"1999","unstructured":"Lewis MB. Cyclosporin neurotoxicity after chemotherapy. Cyclosporin causes reversible posterior leukoencephalopathy syndrome. BMJ. 1999;319:54\u20135.","journal-title":"BMJ"},{"key":"9096_CR48","first-page":"415","volume":"19","author":"Y Ito","year":"1998","unstructured":"Ito Y, Arahata Y, Goto Y, et\u00a0al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 1998;19:415\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"9096_CR49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.49.4.1174","volume":"49","author":"Y Ito","year":"1997","unstructured":"Ito Y, Niwa H, Iida T, et\u00a0al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology. 1997;49:1174\u20135.","journal-title":"Neurology"},{"key":"9096_CR50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.49.3.686","volume":"49","author":"N Delanty","year":"1997","unstructured":"Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology. 1997;49:686\u20139.","journal-title":"Neurology"},{"key":"9096_CR51","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/08830738050200121201","volume":"20","author":"H Ozyurek","year":"2005","unstructured":"Ozyurek H, Oguz G, Ozen S, et\u00a0al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005;20:990\u20133.","journal-title":"J Child Neurol"},{"key":"9096_CR52","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1016\/S0272-6386(01)90015-0","volume":"37","author":"N Kamar","year":"2001","unstructured":"Kamar N, Kany M, Bories P, et\u00a0al. Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients. Am J Kidney Dis. 2001;37:E29.","journal-title":"Am J Kidney Dis"},{"key":"9096_CR53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.47.2.417","volume":"47","author":"BI Karp","year":"1996","unstructured":"Karp BI, Yang JC, Khorsand M, Wood R, Merigan TC. Multiple cerebral lesions complicating therapy with interleukin-2. Neurology. 1996;47:417\u201324.","journal-title":"Neurology"},{"key":"9096_CR54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.69.2.280","volume":"69","author":"T Leniger","year":"2000","unstructured":"Leniger T, Kastrup O, Diener HC. Reversible posterior leukencephalopathy syndrome induced by granulocyte stimulating factor filgrastim. J Neurol Neurosurg Psychiatr. 2000;69:280\u20131.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9096_CR55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1378\/chest.06-0407","volume":"131","author":"M Al-Ansari","year":"2007","unstructured":"Al-Ansari M, Todwal A. A 20-year-old man with status epilepticus and uncontrolled hypertension. Chest. 2007;131:309\u201312.","journal-title":"Chest"},{"key":"9096_CR56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0376-8716(98)00076-3","volume":"51","author":"GJ Marek","year":"1998","unstructured":"Marek GJ, Aghajanian GK. Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action. Drug Alcohol Depend. 1998;51:189\u201398.","journal-title":"Drug Alcohol Depend"},{"key":"9096_CR57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71:533\u201354.","journal-title":"Pharmacol Biochem Behav"},{"key":"9096_CR58","volume-title":"Basic and clinical pharmacology","author":"BG Katzung","year":"2007","unstructured":"Katzung BG. Basic and clinical pharmacology. 10th edn. Europe: Mc Graw Hill Book company; 2007.","edition":"10"},{"key":"9096_CR59","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","volume":"60","author":"JR Bunzow","year":"2001","unstructured":"Bunzow JR, Sonders MS, Arttamangkul S, et\u00a0al. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol. 2001;60:1181\u20138.","journal-title":"Mol Pharmacol"},{"key":"9096_CR60","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1073\/pnas.111134598","volume":"98","author":"MF Egan","year":"2001","unstructured":"Egan MF, Goldberg TE, Kolachana BS, et\u00a0al. Effect of COMT Val108\/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 2001;98:6917\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9096_CR61","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2005-07-2903","volume":"107","author":"PJ O\u2019Connell","year":"2006","unstructured":"O\u2019Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood. 2006;107:1010\u20137.","journal-title":"Blood"},{"key":"9096_CR62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/cp.1999.v66.103402001","volume":"66","author":"JC Alvarez","year":"1999","unstructured":"Alvarez JC, Gluck N, Arnulf I, et\u00a0al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther. 1999;66:617\u201324.","journal-title":"Clin Pharmacol Ther"},{"key":"9096_CR63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0006-3223(95)00449-1","volume":"40","author":"O Spreux-Varoquaux","year":"1996","unstructured":"Spreux-Varoquaux O, Gailledreau J, Vanier B, et\u00a0al. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine? Biol Psychiatry. 1996;40:465\u201373.","journal-title":"Biol Psychiatry"},{"key":"9096_CR64","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jnnp.69.5.704","volume":"69","author":"M Lewis","year":"2000","unstructured":"Lewis M, Maddison P. Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome? J Neurol Neurosurg Psychiatr. 2000;69:704.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9096_CR65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.bmt.1705659","volume":"39","author":"A Moskowitz","year":"2007","unstructured":"Moskowitz A, Nolan C, Lis E, Castro-Malaspina H, Perales MA. Posterior reversible encephalopathy syndrome due to sirolimus. Bone Marrow Transplant 2007;39:653\u20134.","journal-title":"Bone Marrow Transplant"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-008-9096-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-008-9096-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-008-9096-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:30:42Z","timestamp":1738193442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-008-9096-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,30]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["9096"],"URL":"https:\/\/doi.org\/10.1007\/s12028-008-9096-5","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"type":"print","value":"1541-6933"},{"type":"electronic","value":"1556-0961"}],"subject":[],"published":{"date-parts":[[2008,4,30]]}}}